NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Gaudium IVF & Women Health Ltd IPO Listing

Date: 27 February 2026 Exchange: BSE and NSE

The equity shares of Gaudium IVF & Women Health Ltd will be listed in the Indian stock market today, following a strong demand for its initial public offering (IPO). The public issue was open for public subscription from February 20 to 24, with the IPO allotment date being February 25.

The company's shares will be listed on both the BSE and NSE, with trading members informed that the shares will be in the Trade-for-Trade segment for 10 trading days. Additionally, the shares will be part of the Special Pre-open Session (SPOS) on Friday, February 27, 2026, and will be available for trading from 10:00 AM.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Ahead of the listing, investors are watching trends in the grey market premium (GMP) to gauge the estimated listing price. The current Gaudium IVF IPO GMP is ₹0 per share, indicating that the shares are trading equal to their issue price of ₹79 per share. Analysts expect a muted listing of shares.

Key IPO Details:

  • Issue Price: ₹75 to ₹79 per share
  • Fresh Issue: 1.14 crore equity shares worth ₹90 crore
  • Offer-for-Sale (OFS): 94.93 lakh shares amounting to ₹75 crore
  • Total Issue Size: ₹165 crore
  • Subscription Status: Subscribed 7.27 times in total, with 7.60 times subscription in the Retail Individual Investors category and 14.05 times subscription in the Non Institutional Investors segment.

The book running lead manager for the IPO is Sarthi Capital Advisors Pvt. Ltd., and the registrar is Bigshare Services Pvt. Ltd.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Investor Takeaway

Investors should be cautious during Gaudium IVF's trading debut due to potential volatility.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.